Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-12-18
|
pubmed:abstractText |
Treatment of bacterial keratitis requires frequent application of topical antibiotics. We studied the efficacy of a single topical administration of tobramycin incorporated in large multivesicular liposomes and enmeshed in a fibrin sealant on rabbit corneas infected with Pseudomonas aeruginosa. One cornea each of 25 New Zealand albino rabbits was infected with P. aeruginosa. Twenty-four hours later, the animals were randomly divided into five groups of five. Group A received single hourly drops (50 microliters) of fortified tobramycin (14.5 mg/ml, total of 17.4 mg). Group B received a single topical application of 3.5 mg tobramycin, in 0.1 ml multivesicular liposomes, enmeshed in a fibrin sealant with an overlaying bandage contact lens. Group C was treated in the same manner as group B without the addition of fibrin sealant. Groups D and E served as nondrug-treated controls, with group D receiving topical fibrin-enmeshed liposomes devoid of tobramycin and group E receiving hourly topical balanced salt solution (BSS) drops. All animals were killed 24 h after initiation of therapy. Significantly fewer colonies of Pseudomonas were present in corneas of all three treated groups, as compared with the two nondrug-treated control groups (p less than 0.02). There were significantly fewer colonies of Pseudomonas in groups A and B as compared with group C (p less than 0.02). No significant difference was noted between a single administration of topical fibrinen-meshed tobramycin-encapsulated liposomes (group B) and 24 doses of hourly fortified topical tobramycin (group A, p greater than 0.05). Tobramycin-encapsulated megaliposomes may serve as a useful adjunct in treatment of Pseudomonas keratitis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0277-3740
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
393-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1424666-Administration, Topical,
pubmed-meshheading:1424666-Animals,
pubmed-meshheading:1424666-Colony Count, Microbial,
pubmed-meshheading:1424666-Cornea,
pubmed-meshheading:1424666-Corneal Ulcer,
pubmed-meshheading:1424666-Disease Models, Animal,
pubmed-meshheading:1424666-Drug Carriers,
pubmed-meshheading:1424666-Eye Infections, Bacterial,
pubmed-meshheading:1424666-Fibrin,
pubmed-meshheading:1424666-Liposomes,
pubmed-meshheading:1424666-Pseudomonas Infections,
pubmed-meshheading:1424666-Pseudomonas aeruginosa,
pubmed-meshheading:1424666-Rabbits,
pubmed-meshheading:1424666-Random Allocation,
pubmed-meshheading:1424666-Tobramycin
|
pubmed:year |
1992
|
pubmed:articleTitle |
Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
|
pubmed:affiliation |
Bethesda Eye Institute, Department of Ophthalmology, St. Louis University, MO 63110.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|